Newsletter / Paid-only Deconstructing the TRIPS Waiver Discussions: The Susan Sell Interview By Priti Patnaik / 5 Aug 2022
Newsletter / Paid-only No Mandate on Extending WTO TRIPS Agreement Decision to Medicines & Tests: The U.S. By Priti Patnaik / 29 Jul 2022
Newsletter / Paid-only Set into Orbit: WHO Member States Agree to Binding Nature of a New Instrument to Govern Pandemics By Priti Patnaik / 22 Jul 2022
Newsletter / Paid-only Climate Looms Over A New Pandemic Accord, Could Risk Crowding Out Access to Medicines & Equity Issues, Experts Say Newsletter Edition 006 [Treaty Talks] By Priti Patnaik / 15 Jul 2022
Newsletter / Paid-only TRIPS Waiver 2.0 at the WTO: Proponents back at the table to push for therapeutics and diagnostics By Priti Patnaik / 8 Jul 2022
Newsletter / Paid-only WHO Member States Begin to Define Form and Function of a Pandemic Accord Newsletter Edition #005 [Treaty Talks] By Priti Patnaik / 1 Jul 2022
Newsletter / Paid-only Financing to Fight Pandemics Takes Root at the World Bank; Geneva Health Files Tops International Newsletters on Substack By Priti Patnaik / 24 Jun 2022
Newsletter / Paid-only Trade Won, Health Did Not. A Sliver of a Waiver at the WTO. Newsletter Edition #146 [Geneva Health Files: WTO Ministerial Conference Update] By Priti Patnaik / 18 Jun 2022
Newsletter / Paid-only "Power" Trips the Waiver at the WTO, no consensus yet hours before the close of MC12 By Priti Patnaik / 16 Jun 2022
Newsletter / Paid-only Have India and South Africa, Lead Sponsors of the TRIPS Waiver Proposal, Reconciled to a Weak Text? By Priti Patnaik / 13 Jun 2022
Newsletter / Paid-only So Close, Yet So Far: TRIPS Waiver at the WTO Newsletter Edition #143 [Geneva Health Files Newsflash] By Priti Patnaik / 11 Jun 2022
Newsletter / Paid-only Science Diplomacy As a Tool for Pandemic Accord Negotiations By Priti Patnaik / 10 Jun 2022
